Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment | Zendy

Richard T. Schlinkert | Zendy; David M. Nagorney | Zendy; Jon A. van Heerden | Zendy; Martin A. Adson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Intrahepatic Cholangiocarcinoma: Clinical Aspects, Pathology and Treatment

Author(s) -

Richard T. Schlinkert,

David M. Nagorney,

Jon A. van Heerden,

Martin A. Adson

Publication year - 1991

Publication title -

hpb surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.561

H-Index - 26

eISSN - 1607-8462

pISSN - 0894-8569

DOI - 10.1155/1992/93976

Subject(s) - medicine , intrahepatic cholangiocarcinoma , jaundice , stage (stratigraphy) , hepatocellular carcinoma , disease , obstructive jaundice , general surgery , gastroenterology , paleontology , biology

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary tumor of the liver. To further define its clinicopathology and surgical management, we reviewed our experience. Clinical presentations of 32 patients with ICC was similar to that with hepatocellular carcinoma. Jaundice occurred in only 27 percent. ICC was unresectable due to advanced disease stage in 81 percent. Six patients had curative resections with two 5 year disease free survivors. Underlying liver disease was associated with ICC in 34 percent of patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research